Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Depreciation & Amortization (CF) (2016 - 2025)

Palisade Bio has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $1000.0 for Q3 2025.

  • Quarterly Depreciation & Amortization (CF) changed 0.0% to $1000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $3000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $3000.0 for FY2025, 0.0% changed from the prior year.
  • Depreciation & Amortization (CF) was $1000.0 for Q3 2025 at Palisade Bio, roughly flat from $1000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $2000.0 in Q4 2022 and troughed at $1000.0 in Q1 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $1000.0 (2021), against an average of $1166.7.
  • Year-over-year, Depreciation & Amortization (CF) crashed 96.56% in 2021 and then changed 0.0% in 2022.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $1000.0 in 2021, then skyrocketed by 100.0% to $2000.0 in 2022, then crashed by 50.0% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Depreciation & Amortization (CF) are $1000.0 (Q3 2025), $1000.0 (Q2 2025), and $1000.0 (Q1 2025).